Skip to content

Brief CBT for the Treatment of Depression During Inpatient Hospitalization

Brief CBT for the Treatment of Depression During Inpatient Hospitalization

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03011619
Enrollment
0
Registered
2017-01-05
Start date
2017-04-06
Completion date
2018-04-05
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Cognitive Behavioral Therapy (CBT)

Brief summary

Moderately to severely depressed subjects will be randomized to the Control Group, who will receive care as usual, or the CBT Group, who will receive care as usual in addition to the manualized course of Cognitive Behavioral Therapy (CBT).

Detailed description

Participants assigned to the CBT condition will receive the usual standard of care during an inpatient psychiatric hospitalization. This includes but is not limited to medication management, group therapy, and individual therapy. If a patient is randomly assigned to the enhanced CBT group, manualized CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.The training M.D., who is a treating physician on HCC-10, will also intermittently and randomly observe the CBT sessions to ensure the manual properly is being followed. Although the control condition may contain elements of CBT as per the clinician completing the therapy, it is not manualized, does not include specific exercises to be completed between sessions, and is not a course that builds upon skills from the previous day, as in the CBT condition. Participants assigned to the control condition will receive the usual standard of care during an inpatient psychiatric hospitalization. This includes but is not limited to medication management, group therapy, and individual therapy.

Interventions

medication management, group therapy, and individual therapy.

BEHAVIORALCognitive Behavioral Therapy Condition (CBT)

CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with depression according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria on initial assessment on the unit. * Demonstrates at least moderate degree of depressive symptoms on MADRS, HAM-D, and CGI-S. * Provides written informed consent.

Exclusion criteria

* A mental illness other than depression that is the primary cause of treatment, as determined by the Principal Investigator. * A cognitive or neurologic disorder that inhibits ability to engage in CBT.

Design outcomes

Primary

MeasureTime frameDescription
Montgomery-Ashberg Depression Scale (MADRS)15 MinutesA ten-item clinician-administered questionnaire used to measure the severity of depressive symptoms in patients with mood disorders. The ten questions rate the severity of symptoms on scale of 0 (not present), 2 (mild), 4 (moderate), and 6 (severe). It is designed to be sensitive to change, so is often the scale of choice when interventions, such as psychotherapies, electroconvulsive therapy, or drug trials, are being studied.
Hamilton Rating Scale for Depression (HAM-D)20 MinutesClinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness.
Clinical Global Impression Severity Scale (CGI-S)20 MinutesSingle-item rating scale of the clinician's assessment of the global severity of depressive symptoms in relation to the clinician's total experience with depressed patients. Severity is rated on a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026